查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2028 年的皮內註射市場預測-COVID-19 的影響和方法、應用和最終用戶的全球分析
市場調查報告書
商品編碼
1126276

到 2028 年的皮內註射市場預測-COVID-19 的影響和方法、應用和最終用戶的全球分析

Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 197 Pages | 訂單完成後即時交付

價格

皮內註射市場預計將從 2021 年的 35.1326 億美元增至 2028 年的 74.157 億美元，2021 年至 2028 年的複合年增長率為 11.3%。

本報告涵蓋了市場上普遍存在的趨勢以及推動市場增長的因素。皮內註射市場的增長歸因於皮內疫苗接種的增加、各種疾病的發病率增加以及整容手術的接受度不斷提高。此外，製造商的戰略發展預計將成為預測期內市場的主要趨勢。然而，與皮內註射相關的風險、並發症和劑量限制阻礙了皮內註射市場的增長。

許多發展中國家和發達國家現在將醫療保健行業視為其關鍵領域之一，醫療保健成本呈指數級增長，旨在提供更好的基礎設施和醫療設施。帶來各種製藥公司都在努力開發理想的藥物和設備，以滿足日益增長的全球需求，而皮內註射是用於治療、診斷、疫苗接種、整容手術等的潛在設備之一。皮內接種的日益普及被認為是全球皮內註射市場的主要驅動因素，因為它提供了優於傳統接種方法的幾個優勢。皮內接種可減少抗原的潛在劑量，改善疫苗產生的免疫反應，並有助於減少與疫苗接種相關的焦慮。皮內接種的發展使得大量人群能夠以相對較小的疫苗生產量接種疫苗，並且與常規接種疫苗和難以共病的人群相比，不良事件發生的可能性也更低，接種疫苗也是可能的。近年來，COVID19、甲肝疫苗、乙肝疫苗、流感疫苗、脊髓灰質炎疫苗、麻疹疫苗、狂犬病疫苗、破傷風疫苗、黃熱病疫苗、白喉/破傷風/百日咳疫苗等皮內疫苗已經普及。為了提高反應率，幾家主要的製藥和生物技術公司正在努力開發新型皮內給藥以及商業疫苗。 2020 年，Sanofi獲得了 FDA 批准的皮內疫苗 Fluzone，該疫苗正迅速超越流感疫苗市場，並有望取代這些疾病的先天性治療。

世界上超過三分之一的人口也有患肺結核的風險，過去幾年進行的肺結核皮膚測試數量急劇增加。皮內結核菌素注射器用於診斷結核病，目前由幾家主要的藥物輸送設備製造商開發。與此同時，在過去十年中，過敏症的患病率增加了幾倍。這主要是由於公眾對幾種過敏相關疾病的認識有所提高。皮內註射已被用作對幾種過敏原進行敏感性測試的理想設備。

除此之外，局部整容手術也在迅速增長，據 ISAPS 估計，從 2011 年到 2017 年，非手術整容手術的數量增加了 51.4%。與此同時，據信許多新的皮內註射劑將獲得批准，因為皮內註射劑可以提供更好的反應，減少劑量要求和不良事件。研究還表明，皮內給藥可提高抗癌藥物和免疫劑的吸收，可用於給藥基因治療藥物。此外，COVID19 病例的持續增加也表明了該領域的未來潛力。隨著世界人口的增加，預計在不久的將來患者人數將增加，皮內註射的需求預計也會增加。此外，PharmaJet 的 Tropis ID 等新型皮內給藥裝置在輸送針對各種疾病的藥物方面表現出卓越的功效，從而擴大了皮內產品的治療範圍。

除了皮內註射的優點外，這些給藥裝置也存在一些缺點，如注射部位反應和劑量限制等，這些都是製約皮內註射市場的主要因素。在皮內施用活性成分後，觀察到注射部位皮膚的變色、腫脹、發紅、瘙癢和炎症。為了克服與註射部位感染相關的挑戰，研究人員正在努力確定注射藥物的理想部位，具體取決於藥物的性質和所需的作用。

在過去的幾年中，皮內註射相關的程序和設備不斷創新，並為該領域的發展引入了多項新技術。在過去十年中，與多種並發症相關的疫苗接種和診斷率呈指數增長，最終增加了皮內註射的接受度。

公司在皮內註射市場採用了幾種有機和無機策略。有機戰略主要包括產品發布和產品批准。此外，皮內註射市場的無機增長戰略是收購、合作和夥伴關係。這些增長戰略使市場參與者能夠擴大業務並增強其地域影響力，從而促進皮內註射市場的整體增長。此外，收購和合作戰略有助於市場參與者加強其客戶群並擴大其產品組合。下面列出了皮內註射市場主要參與者的一些顯著發展。

2021 年 11 月，NanoPass Technologies 和Aesthetic Management Partners達成協議，開始在美國將 NanoPass 的 MicronJet 600 皮內給藥裝置商業化。

2021 年 8 月，PharmaJet 和 Zydus Cadila 獲得了印度藥品管理局 (DCGI) 的 ZyCoV-D 緊急使用授權 (EUA)，ZyCoV-D 是世界上第一個用於 COVID-19 的質粒 DNA 疫苗。 ZyCoV-D 是一種使用 PharmaJet Tropis 無針注射系統的單次給藥疫苗。

在準備皮內註射劑市場報告時，世界衛生組織 (WHO)、疾病控制和預防中心 (CDC)、國民健康保險等被引用為主要和次要信息。

內容

第一章介紹

  • 調查範圍
  • Insight Partners 研究報告指南
  • 市場細分
    • 全球皮內註射劑市場-按方法
    • 全球皮內註射劑市場-按應用
    • 全球皮內註射劑市場 - 按最終用戶分類
    • 全球皮內註射劑市場 - 按地區

第 2 章. 要點

第三章研究方法

  • 範圍
  • 二次調查
  • 初步調查

第四章皮內註射市場情況

  • PEST 分析
    • 北美 - PEST 分析
    • 歐洲 - PEST 分析
    • 亞太地區的 PEST 分析
    • 中東和非洲的 PEST 分析
    • 拉丁美洲 - PEST 分析
  • 專家意見

第 5 章皮內註射劑市場 - 主要市場動態

  • 主要市場驅動因素
    • 增加皮內接種
    • 發病率增加
    • 對整容手術的接受度提高
  • 主要市場製約因素
    • 與皮內註射相關的風險、並發症和劑量限制
  • 主要市場機會
    • 發達國家和發展中國家的顯著增長機會
  • 未來趨勢
    • 製造商的戰略發展
  • 驅動因素和製約因素的影響分析

第 6 章全球皮內註射劑市場 - 分析

  • 皮下注射劑全球市場收入、預測與分析
  • 全球皮下注射劑市場：按地區劃分的預測和分析
  • 主要參與者的市場定位

第 7 章：皮內註射劑全球市場收入和到 2028 年的預測 - 按方法分類

  • 2021 年和 2028 年按方法分列的全球皮內註射劑市場 (%)
  • 普通尺寸的針（MANTOUX）
  • 短針
  • 無針

第 8 章全球皮下注射劑市場收入和到 2028 年的預測 - 應用

  • 2021 年和 2028 年按應用分列的皮內註射劑全球市場份額 (%)
  • 結核菌素皮膚反應
  • 過敏測試
  • 局部美容
  • 其他
    • 其他市場展望與分析

第 9 章皮內註射劑市場分析 - 最終用戶

  • 2021 年和 2028 年全球皮內註射劑市場：按最終用戶分類（%）
  • 醫院
  • 診斷實驗室
  • 學術和研究機構
  • 其他

第 10 章皮內註射劑市場收入和到 2028 年的預測 - 區域分析

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
    • 阿聯酋
    • 沙特阿拉伯
    • 南非
    • 其他中東和非洲
  • 中美洲和南美洲
    • 中美洲和南美洲
      • 阿根廷
      • 巴西
      • 其他拉丁美洲

第 11 章 COVID-19 大流行對皮內註射市場的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第 12 章皮內註射劑市場 - 行業格局

  • 市場概覽
  • 發展狀況

第 13 章公司簡介

  • BD
  • West Pharmaceutical Services, Inc.
  • Terumo Corporation
  • NanoPass
  • Pharmajet
  • Idevax
  • EUNSUNG GLOBAL
  • Crossject
  • Cardinal Health Inc.
  • Hindustan Syringes and Medical Devices Ltd

第十四章附錄

  • 關於 The Insight Partners
  • 詞彙表
Product Code: TIPRE00019998

The intradermal injection market is projected to reach US$ 7,415.70 million by 2028 from US$ 3,513.26 million in 2021 and is expected to register a CAGR of 11.3% from 2021 to 2028.

The report highlights trends prevailing in the market and factors driving the market growth. The intradermal injection market growth is attributed to the increasing intradermal vaccination, increasing incidence of various diseases, and rising acceptance of aesthetic procedures. Additionally, stratageic developments by manufacturers are likely to emerge as a significant trend in the market during the forecast period. However, the risks, complications, and dosing limitations associated with Intradermal Injections hamper the growth of the intradermal injection market.

Most of the developing and developed countries are currently considering the healthcare sector as one of the essential segments, which resulted in the exponential increase in healthcare expenditure with the aim of providing better infrastructure and medical facilities. For fulfilling the rising global demand, various pharmaceutical giants are working to develop ideal drugs and devices, and intradermal injections are emerging as one of the potential devices used for the treatment, diagnosis, vaccination, and cosmetic procedures. Rising acceptance of intradermal vaccination is believed to act as major driver for the global intradermal injection market as it has several advantages over the conventional method of vaccination. Intradermal vaccination helps in reducing the potential dose of antigens, improves the immune response generated by the vaccine and decrease the anxiety associated with the vaccination. By developing intradermal injection, a large population can be vaccinated with comparatively lesser production of the vaccine while this method is also able to vaccinate the difficult group of population with comorbidities as chances of adverse events is low as compared to conventional vaccination. Recently, several intradermal COVID19 vaccines, hepatitis A vaccine, hepatitis B vaccine, Influenza vaccines, polio vaccine measles vaccine, Rabies vaccine, tetanus vaccine, yellow fever vaccine, diphtheria-tetanus-pertussis vaccine etc. shows improvement in the overall response rate and hence several leading pharmaceutical and biotechnological companies are currently working on the development of intradermal injections of the new as well as commercially available vaccines. In 2020, Sanofi received the FDA approval for its intradermal vaccine of Influenza names Fluzone, which is rapidly overtaking the influenza vaccine market and replacing the congenital treatments for these diseases.

Further, more than one-third of the global population has a risk of developing tuberculosis, and an intense increase in the number of tuberculosis skin test procedures has been observed during the past few years. Intradermal tuberculin syringes are used for diagnosing tuberculosis, and several leading manufacturers of drug delivery devices are currently developing these tuberculin syringes. Along with this, the prevalence of allergies has increased several times during the past decade, mainly due to the rise in awareness among the population about several allergy-related conditions. The intradermal injections are used as an ideal device for conducting sensitivity tests for several allergens.

In addition to this, the local aesthetic procedures are also increasing rapidly, and the number of nonsurgical cosmetic procedures has increased by 51.4% from 2011 to 2017 as per the estimates of ISAPS. Along with this, many new intradermal vaccinations are believed to get approval as intradermal vaccination is able to produce better response along with reduction in the required dose and adverse events. . Along with this, several studies concluded that the intradermal injection could improve the uptake of various cancers and immunological drugs while it can also be used to deliver the gene therapies. Further, continuously increasing cases of COVID19 is also indicating towards the future potential of this segment as various intradermal preparations are under investigation and about to get approved in near future. As the global population is increasing continuously, the number of cases will also increase in near future, which ultimately increases the demand of intradermal injection. Further, the novel intradermal injection devices such as Tropis ID of Pharmajet shows prominent results in delivering various drugs for targeting a wide range of diseases and expands the therapeutic area of the intradermal products.

Besides the benefits of intradermal injection, several drawbacks are also associated with these drug delivery devices including injection site reactions and dosing limitations, which are acting as major restraints for the intradermal injection market. It is observed that skin discoloration, swelling, redness, itching and irritation occurs at the site of injection after the intradermal delivery of active ingredient. For overcoming the challenges related to the injection site infections, the researchers are working to identify ideal site for injecting the drug depending upon the nature of drug and required action.

During the past few years, intradermal injections associated procedures and devices have undergone continuous innovations, and several novel technologies are incorporated in this segment for the advancement of this sector. The vaccination and diagnosis rates related to several complications have increased exponentially during the last decade, ultimately increasing the acceptance of intradermal injections.

Several organic and inorganic strategies are adopted by companies in the intradermal injection market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the intradermal injection market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and augment their geographic presence, thereby contributing to the overall growth of intradermal injection market. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few of the noteworthy developments by key players in the intradermal injection market are listed below.

In November 2021, NanoPass Technologies and Aesthetic Management Partners entered into an agreement to initiate the commercialization of NanoPass's MicronJet 600 intradermal delivery device in the US.

In August 2021, PharmaJet and Zydus Cadila received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world's first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is solely administered utilizing the PharmaJet Tropis Needle-free Injection System.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness are among the primary and secondary sources referred while preparing the report on the intradermal injection market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Intradermal Injection market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global Intradermal Injection market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distributions.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Intradermal Injections Market - By Method
    • 1.3.2 Global Intradermal Injections Market - By Application
    • 1.3.3 Global Intradermal Injections Market - By End User
    • 1.3.4 Global Intradermal Injections Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Intradermal Injections Market Landscape

  • 4.1 Overview
  • 4.2 PEST ANALYSIS
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia-Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa - PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis
  • 4.3 EXPERT OPINIONS

5. Intradermal Injections Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Intradermal Vaccination
    • 5.1.2 Increasing Incidences of diseases
    • 5.1.3 Rising Acceptance of Aesthetic Procedures
  • 5.2 Key Market Restraints
    • 5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections
  • 5.3 Key Market Opportunities
    • 5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Strategic Developments by Manufacturers
  • 5.5 Impact Analysis of Drivers And Restraints

6. Intradermal Injections Market- Global Analysis

  • 6.1 Global Intradermal Injections Market Revenue Forecast and Analysis
  • 6.2 Global Intradermal Injections Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Global Intradermal Injections Market Revenue And Forecasts To 2028- By Method

  • 7.1 Overview
  • 7.2 Global Intradermal Injections Market, By Method, 2021 & 2028 (%)
  • 7.3 Normal-Sized Needles (MANTOUX)
    • 7.3.1 Overview
    • 7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)
  • 7.4 Short Needles
    • 7.4.1 Overview
    • 7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.4.3 Intradermal Microinjection
      • 7.4.3.1 Overview
      • 7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.4.4 Microneedle Arrays
      • 7.4.4.1 Overview
      • 7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.4.5 Tattoo Devices
      • 7.4.5.1 Overview
      • 7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Without Needles
    • 7.5.1 Overview
    • 7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.5.3 Intradermal Liquid Jet Injectors
      • 7.5.3.1 Overview
      • 7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
    • 7.5.4 Ballistic Intradermal Injectors
      • 7.5.4.1 Overview
      • 7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

8. Intradermal Injections Market Revenue and Forecasts To 2028 - Application

  • 8.1 Overview
  • 8.2 Global Intradermal Injections Market Share by Application - 2021 & 2028 (%)
  • 8.3 Tuberculin Skin Testing
    • 8.3.1 Overview
    • 8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Allergy Testing
    • 8.4.1 Overview
    • 8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Local Aesthetics
    • 8.5.1 Overview
    • 8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 OTHERS
    • 8.6.1 Overview
    • 8.6.2 Others Market Forecast and Analysis

9. Intradermal Injections Market Analysis - End User

  • 9.1 Overview
  • 9.2 Global Intradermal Injections Market, By End User, 2021 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 OTHERS
    • 9.6.1 Overview
    • 9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

10. Intradermal Injections Market Revenue And Forecasts To 2028 - Geographical Analysis

  • 10.1 North America: Intradermal Injections Market
    • 10.1.1 Overview
    • 10.1.2 North America: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
      • 10.1.3.1 North America: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.1.3.2 North America: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.1.4 North America: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
    • 10.1.5 North America: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
    • 10.1.6 North America: Intradermal Injections Market, by Country, 2021 & 2028 (%)
      • 10.1.6.1 US: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
        • 10.1.6.1.3.1 US: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.1.6.1.3.2 US: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.1.6.1.4 US: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
        • 10.1.6.1.5 US: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
      • 10.1.6.2 Canada: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
        • 10.1.6.2.3.1 Canada: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.1.6.2.3.2 Canada: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
      • 10.1.6.3 Mexico: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
        • 10.1.6.3.3.1 Mexico: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.1.6.3.3.2 Mexico: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
  • 10.2 Europe: Intradermal Injections Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.3.1 Europe: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.2.3.2 Europe: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.2.4 Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    • 10.2.5 Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6 Europe: Intradermal Injections Market, by Country, 2021 & 2028 (%)
      • 10.2.6.1 Germany: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3.1 Germany: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.1.3.2 Germany: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.5 Germany: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2 France: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 France: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 France: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3.1 France: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.2.3.2 France: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.2.4 France: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.5 France: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3 UK: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 UK: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 UK: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3.1 UK: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.3.3.2 UK: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.3.4 UK: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.5 UK: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4 Italy: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3.1 Italy: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.4.3.2 Italy: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.5 Italy: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5 Spain: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3.1 Spain: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.5.3.2 Spain: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.5 Spain: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3.1 Rest of Europe: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.2.6.6.3.2 Rest of Europe: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 10.3 Asia Pacific Intradermal Injections Market Revenue and Forecasts To 2028
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 10.3.3.1 Asia Pacific: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.3.3.2 Asia Pacific: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    • 10.3.5 Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.6 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
      • 10.3.6.1 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.3 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.1.3.1 Japan: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.1.3.2 Japan: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.1.4 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.1.5 Japan: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.3 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.2.3.1 China: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.2.3.2 China: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.2.4 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.2.5 China: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.3 India Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.3 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.3.3.1 India: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.3.3.2 India: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.3.4 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.3.5 India: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.4.3.1 South Korea: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.4.3.2 South Korea: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.4.5 South Korea: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.5 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.5.3.1 Australia: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.5.3.2 Australia: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.5.5 Australia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.3.6.6.3.1 Rest of Asia Pacific: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.3.6.6.3.2 Rest of Asia Pacific: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Middle East & Africa Intradermal Injections Market Revenue and Forecasts To 2028
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 10.4.3.1 Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.4.3.2 Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.4.4 Middle East & Africa: Intradermal Injection Market Revenue and Forecasts to 2028, By Application (US$ Million)
    • 10.4.5 Middle East & Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.6 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
      • 10.4.6.1 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.1.3 UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.4.6.1.3.1 UAE: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.4.6.1.3.2 UAE: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.4.6.1.4 UAE: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.1.5 UAE: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.2.3 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.4.6.2.3.1 Saudi Arabia: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.4.6.2.3.2 Saudi Arabia: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.4.6.2.4 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.2.5 Saudi Arabia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.3.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.4.6.3.3.1 South Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.4.6.3.3.2 South Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.4.6.3.4 South Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.3.5 South Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.4 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.4.6.4.3.1 Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.4.6.4.3.2 Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.4.5 Rest of Middle East and Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 South And Central America Intradermal Injections Market Revenue and Forecasts To 2028
    • 10.5.1 Overview
    • 10.5.2 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.5.3 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
      • 10.5.3.1 South and Central America: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
      • 10.5.3.2 South and Central America: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    • 10.5.4 South and Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    • 10.5.5 South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.6 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
      • 10.5.6.1 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.5.6.1.3 Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.5.6.1.3.1 Argentina: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.5.6.1.3.2 Argentina: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.5.6.1.4 Argentina: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.1.5 Argentina: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.5.6.2.3 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.5.6.2.3.1 Brazil: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.5.6.2.3.2 Brazil: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.5.6.2.4 Brazil: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.2.5 Brazil: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.3 Rest of South and Central America: Intradermal Injections Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South and Central America: Intradermal Injections Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 10.5.6.3.3.1 Rest of South & Central America: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
        • 10.5.6.3.3.2 Rest of South & Central America: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.3.5 Rest of South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic On Intradermal Injections Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Intradermal Injections Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Developments
    • 12.2.1 Overview

13. Company Profiles

  • 13.1 BD
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 West Pharmaceutical Services, Inc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Terumo Corporation
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 NanoPass
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Pharmajet
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Idevax
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 EUNSUNG GLOBAL
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Crossject
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Cardinal Health Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Hindustan Syringes and Medical Devices Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America Intradermal Injections Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 10. US Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Canada: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Canada Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Canada Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Mexico: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Mexico Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Mexico Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Europe: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Europe: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Germany: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Germany: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Germany: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Germany: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Germany: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. France: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. France: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. France: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. France: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. France: Intradermal Injections Market
  • Table 36. France: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. UK: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. UK: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. UK: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. UK: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 41. UK: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Italy: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Italy: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Italy: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Italy: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Italy: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Spain: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Spain: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Spain: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Spain: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Spain: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Europe: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Europe: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Rest of Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Rest of Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million).
  • Table 58. Asia Pacific: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Asia Pacific: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 61. Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 63. Japan: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Japan: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 66. Japan: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 68. China: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. China: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 71. China: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 73. India: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. India: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 76. India: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 78. South Korea: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. South Korea: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 81. South Korea: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 83. Australia: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 84. Australia: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 85. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 86. Australia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 88. Rest of Asia Pacific: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 89. Rest of Asia Pacific: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 90. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 91. Rest of Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 92. Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 93. Middle East & Africa: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 94. Middle East & Africa: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 95. Middle East & Africa: Intradermal Injection Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 96. Middle East & Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 97. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 98. UAE: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 99. UAE: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 100. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 101. UAE: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 102. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 103. Saudi Arabia: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 104. Saudi Arabia: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 105. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 106. Saudi Arabia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 107. South Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 108. South Africa: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 109. South Africa: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 110. South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 111. South Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 112. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 113. Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 114. Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 115. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 116. Rest of Middle East and Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 117. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 118. South and Central America: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 119. South and Central America: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 120. South and Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 121. South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 122. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 123. Argentina: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 124. Argentina: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 125. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 126. Argentina: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 127. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 128. Brazil: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 129. Brazil: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 130. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 131. Brazil: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 132. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 133. Rest of South & Central America: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 134. Rest of South & Central America: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
  • Table 135. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 136. Rest of South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 137. Developments Done by Companies
  • Table 138. Glossary of Terms

List Of Figures

  • Figure 1. Intradermal Injections Market Segmentation
  • Figure 2. Intradermal Injections Market, By Region
  • Figure 3. Global Intradermal Injections Market Overview
  • Figure 4. Normal Sized Needles Segment by Method Held Largest Share of Intradermal Injection Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Intradermal Injections Market, by Geography (US$ Million)
  • Figure 7. Global Intradermal Injections Market- Leading Country Markets (US$ Million)
  • Figure 8. North America PEST Analysis
  • Figure 9. Europe PEST Analysis
  • Figure 10. Asia-Pacific PEST Analysis
  • Figure 11. Middle East and Africa PEST Analysis
  • Figure 12. South and Central America PEST Analysis
  • Figure 13. Intradermal Injection Market Impact Analysis of Drivers and Restraints
  • Figure 14. Global Intradermal Injections Market- Revenue Forecast and Analysis - 2021 - 2028
  • Figure 15. Global Intradermal Injections Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 16. Market Positioning of Key Players in Global Intradermal Injections Market
  • Figure 17. Global Intradermal Injections Market, by Method, 2021 & 2028 (%)
  • Figure 18. Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 19. Short Needles: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 20. Intradermal Microinjection: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 21. Microneedle Arrays: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 22. Tattoo Devices: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 23. Without Needle: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 24. Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 25. Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 26. Global Intradermal Injections Market Share by Application - 2021 & 2028 (%)
  • Figure 27. Tuberculin Skin Test Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 28. Allergy Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 29. Local Aesthetic Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 30. Others Intradermal Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 31. Global Intradermal Injections Market, by End User, 2021 & 2028 (%)
  • Figure 32. Hospital : Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 33. Diagnostic Laboratories : Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 34. Academic & Research Institutes : Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 35. Others: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 36. North America: Intradermal Injections Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 37. North America Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. North America: Intradermal Injections Market, by Country, 2021 & 2028 (%)
  • Figure 39. US: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Canada: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Mexico: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Europe: Intradermal Injections Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 43. Europe: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Europe: Intradermal Injections Market, by Country, 2021 & 2028 (%)
  • Figure 45. Germany: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. France: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. UK: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Italy: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Spain: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Rest of Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Asia Pacific Intradermal Injections Market Overview, by Country (2021)
  • Figure 52. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 53. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 54. Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 55. China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 56. India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 57. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 58. Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 59. Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Middle East & Africa Intradermal Injections Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 61. Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 62. Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 63. UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 64. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 65. South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 66. Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 67. South and Central America Intradermal Injections Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 68. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 69. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 70. Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 71. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 72. Rest of South and Central America: Intradermal Injections Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 74. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 76. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 77. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets